Cellectis
CLLS
78 hedge funds and large institutions have $253M invested in Cellectis in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 35 reducing their positions, and 10 closing their positions.
0.12% less ownership
Funds ownership: 36.06% → 35.95% (-0.12%)
4% less funds holding
Funds holding: 81 → 78 (-3)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
18% less capital invested
Capital invested by funds: $310M → $253M (-$57M)
37% less call options, than puts
Call options by funds: $524K | Put options by funds: $831K
49% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 35
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$21.2M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$17.4M |
| 3 |
BlackRock
New York
|
+$1.67M |
| 4 |
KBC Group
Brussels,
Belgium
|
+$1.54M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$7.71M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.01M |
| 3 |
Morgan Stanley
New York
|
-$2.41M |
| 4 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$2.22M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$1.74M |
CLLS Hedge Fund Activity: Q2 2021 in Review
78 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2021, worth a combined $253M — down 18% from $310M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CLLS and 9 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 18 added.
The largest buyer was Principal Financial Group, opening a new position worth an estimated $21.2M. The largest seller was ARK Investment Management, cutting an estimated $7.71M.
- 78 institutional investors held Cellectis (CLLS) as of Q2 2021, down from 81 in Q1 2021.
- Funds reported $253M of Cellectis stock for Q2 2021, down 18% quarter-over-quarter.
- 9 funds opened new Cellectis positions in Q2 2021 and 10 closed out, a net change of -1 holder.
- The largest Cellectis buyer in Q2 2021 was Principal Financial Group, an estimated $21.2M added.
- The largest Cellectis seller in Q2 2021 was ARK Investment Management, an estimated $7.71M sold.
Based on aggregated 13F filings for Q2 2021.